COMP
protein-codingcartilage oligomeric matrix protein, the group of Thrombospondin family
Gene summary
The protein encoded by this gene is a noncollagenous extracellular matrix (ECM) protein. It consists of five identical glycoprotein subunits, each with EGF-like and calcium-binding (thrombospondin-like) domains. Oligomerization results from formation of a five-stranded coiled coil and disulfides. Binding to other ECM proteins such as collagen appears to depend on divalent cations. Contraction or expansion of a 5 aa aspartate repeat and other mutations can cause pseudochondroplasia (PSACH) and multiple epiphyseal dysplasia (MED). [provided by RefSeq, Jul 2016]
- PSACH
- EDM1
- EPD1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~8.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: Unknown
Disease ID:MONDO:0008322
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0100593
Submitter: ClinGen
*COMP* has been first reported in association with autosomal dominant *COMP*-related skeletal dysplasia in 1993 (Hecht et al., PMID: 8307577). *COMP* has also been associated with multiple epiphyseal dysplasia and pseudoachondroplasia. There is no clear locus specificity of variation within the gene to determine a clear genotype-phenotype correlation and there is substantial phenotypic overlap between the two disease entities. Therefore, per criteria outlined by the ClinGen Lumping and Splitting guidelines, they have been lumped as one disease entity, *COMP*-related skeletal dysplasia. Evidence supporting this gene-disease relationship includes case-level, segregation, and experimental data. At least 15 unique variants (missense, inframe indels) in *COMP* have been identified in 15 patients with skeletal dysplasia in 10 publications (PMIDs: 8307577, 9388247, 21644213, 21922596, 27330822, 29899997, 26920793, 21965141, 11565064, 15756302). Additionally, variants in *COMP* segregated with disease in 15 additional family members (PMIDs: 8307577, 11565064, 15756302, 26920793). This gene-disease relationship is supported by mouse models, expression studies, and in vitro functional assays (PMIDs: 20578249, 18576344, 11084047, 12801484, 17570134, 22006726, 10753957, 1556121). In summary, *COMP* is definitively associated with autosomal dominant *COMP*-related skeletal dysplasia. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the Skeletal Disorders Gene Curation Expert Panel on the meeting date February 28th, 2025 (SOP Version 11).
Inheritance Pattern: AD
Disease ID:MONDO:0008322
Submitter: Illumina
Inheritance Pattern: AD
Disease ID:MONDO:0007561
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0008322
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0007561
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0008322
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0100593
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Musculoskeletal
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to COMP variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000095.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 13 | 124 | 5 | 142 | ||
| missense | 49 | 119 | 338 | 23 | 529 | |
| nonsense | 13 | 13 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 2 | 3 | 13 | 18 | ||
| splice donor/acceptor (+/-2bp) | 1 | 4 | 12 | 17 | ||
| Total | 52 | 126 | 390 | 147 | 5 | 720 |
Highest pathogenic variant AF is 0.000037644313
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000086.2 | 19 | MANE Select | |
| Ensembl | ENSP00000222271.2 | 19 | MANE Select | |
| Ensembl | ENSP00000403792.1 | 18 | Standard | |
| Ensembl | ENSP00000403792.1 | 18 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- PI3K-Akt signaling pathway - Homo sapiens (human)
- ECM-receptor interaction - Homo sapiens (human)
- Focal adhesion - Homo sapiens (human)
- Phagosome - Homo sapiens (human)
- Malaria - Homo sapiens (human)
Biological Process
- skeletal system development
- chondrocyte development
- apoptotic process
- response to unfolded protein
- protein secretion
Molecular Function
- protease binding
- integrin binding
- extracellular matrix structural constituent
- calcium ion binding
- protein binding
Cellular Component
- extracellular region
- extracellular space
- extracellular matrix
- protein-containing complex
- collagen-containing extracellular matrix
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000222271
- Coding exons
- 19
- Length
- 8541
- Individuals with no LoFs
- 125684
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 64
- Defined
- 125748
- p
- 0.000255
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.78 | 348 | 455 | 0.765 | 0.0000270 | 4976 |
| Missense (PolyPhen) | 174 | 242.51 | 0.71749 | 2696 | ||
| Synonymous | 0.559 | 178 | 188 | 0.948 | 0.0000123 | 1408 |
| Loss of Function | 2.73 | 21 | 39.5 | 0.531 | 0.00000191 | 411 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00044 | 0.00037 | rare |
| Latino/Admixed American | 0.00020 | 0.00020 | rare |
| Ashkenazi Jewish | 0.00069 | 0.00069 | rare |
| East Asian | 0.00023 | 0.00022 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00024 | 0.00024 | rare |
| South Asian | 0.00042 | 0.00042 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May play a role in the structural integrity of cartilage via its interaction with other extracellular matrix proteins such as the collagens and fibronectin. Can mediate the interaction of chondrocytes with the cartilage extracellular matrix through interaction with cell surface integrin receptors. Could play a role in the pathogenesis of osteoarthritis. Potent suppressor of apoptosis in both primary chondrocytes and transformed cells. Suppresses apoptosis by blocking the activation of caspase-3 and by inducing the IAP family of survival proteins (BIRC3, BIRC2, BIRC5 and XIAP). Essential for maintaining a vascular smooth muscle cells (VSMCs) contractile/differentiated phenotype under physiological and pathological stimuli. Maintains this phenotype of VSMCs by interacting with ITGA7 (By similarity). {ECO:0000250, ECO:0000269|PubMed:16051604, ECO:0000269|PubMed:16542502, ECO:0000269|PubMed:17993464}.;
- Disease
- DISEASE: Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]: A generalized skeletal dysplasia associated with significant morbidity. Joint pain, joint deformity, waddling gait, and short stature are the main clinical signs and symptoms. Radiological examination of the skeleton shows delayed, irregular mineralization of the epiphyseal ossification centers and of the centers of the carpal and tarsal bones. Multiple epiphyseal dysplasia is broadly categorized into the more severe Fairbank and the milder Ribbing types. The Fairbank type is characterized by shortness of stature, short and stubby fingers, small epiphyses in several joints, including the knee, ankle, hand, and hip. The Ribbing type is confined predominantly to the hip joints and is characterized by hands that are normal and stature that is normal or near-normal. {ECO:0000269|PubMed:11084047, ECO:0000269|PubMed:11565064, ECO:0000269|PubMed:21922596, ECO:0000269|PubMed:7670472, ECO:0000269|PubMed:9021009, ECO:0000269|PubMed:9184241, ECO:0000269|PubMed:9452026, ECO:0000269|PubMed:9463320, ECO:0000269|PubMed:9921895}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Pseudoachondroplasia (PSACH) [MIM:177170]: A skeletal dysplasia usually manifesting in the second year of life and characterized by moderate to severe disproportionate short stature, deformity of the lower limbs, brachydactyly, ligamentous laxity, and degenerative joint disease. {ECO:0000269|PubMed:10852928, ECO:0000269|PubMed:11084047, ECO:0000269|PubMed:11746044, ECO:0000269|PubMed:11746045, ECO:0000269|PubMed:21922596, ECO:0000269|PubMed:7670471, ECO:0000269|PubMed:7670472, ECO:0000269|PubMed:9184241, ECO:0000269|PubMed:9452026, ECO:0000269|PubMed:9452063, ECO:0000269|PubMed:9463320, ECO:0000269|PubMed:9921895}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.722
Intolerance Scores
- LoFtool
- 0.175
- RVIS EVS
- -0.49
- RVIS percentile EVS
- 22.65
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.380
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |